Aitrasound® Medical Group Announces Completion of a Pre-A Financing Round of Nearly 60 Million Hong Kong Dolla

Ms. Mingzhu Han, CEO of the company said, "The launch of the new group brand Aitrasound® marks our upgrade from an innovative medical equipment and technology company to an integrated innovative medical technology service platform for chronic disease screening and treatment. After incorporating sports therapy as well as traditional Chinese and Western medicine approaches, we will provide precise rehabilitation and minimally invasive surgical solutions based on AI medical imaging technology for medical institutions, schools, and families. Through programs such as 3D ultrasound medical assessment, AI digital rehabilitation, and 3D minimally invasive surgical guidance, we empower medical institutions to jointly build distinctive outpatient treatment systems.

 

Next, we will also establish an Internet hospital to make assessments and rehabilitation not limited to specific hospital settings, increase patient participation, and integrate treatment into daily life. In terms of global expansion, we will obtain US FDA Class II medical device certification in the third quarter of 2024 and officially enter the US market."

 

Mr. Chibo Tang, Managing Partner of Gobi Partners, said, "We have long focused on investing in the Greater Bay Area's companies owing independently developed original technologies and continuously facilitating them to expand application scenarios and markets. As a startup team originating from Hong Kong, Aitrasound® Medical Group combines original technology elements spanning across artificial intelligence, hard technology, and healthcare. The core team has rich experiences in commercializing technology. They utilize local advantages to expand diversified revenue sources domestically and build a Chinese original brand with distinctive products in overseas markets. We empower entrepreneurs from early to growth stages, focus on emerging industries and markets, and look forward to seeing more excellent enterprises in the Greater Bay Area making their markets in the world."

 

Its flagship product Scolioscan® is the world's first and only ultrasonic scoliosis assessment system, filling the global technological gap in spine imaging, i.e. between radioactive X-ray imaging and inaccurate body surface contour measurement. It owns over 30 patent families with a total of more than 100 patents. Scolioscan® has been installed for clinical applications in hospitals and clinics in Europe, Australia, Mainland China, and Hong Kong, totally over 20 countries and regions. It has obtained Class II medical device certifications, including the EU CE, Australia ARTG, China NMPA, Thailand FDA and Malaysia MDA.

The team has been collaborating with internationally renowned hospitals and universities on various clinical research and has published over 30 research papers in top international journals in fields such as orthopedics and kinesiology, ultrasound, biomedical engineering, artificial intelligence, and pattern recognition to demonstrate the accuracy and reliability of the technology as well as various clinical applications.

The units installed with Scolioscan® include orthopedics, rehabilitation, and physical examination departments of hospitals, massage therapy department of traditional Chinese medicine hospitals , children health departments of maternity and child healthcare hospitals, work injury rehabilitation hospitals, sports rehabilitation hospitals, private orthopedic rehabilitation clinics, and traditional Chinese medicine clinics.

Since establishment, Aitrasound® team has won numerous international and domestic innovation and entrepreneurship awards: In 2023, it is the only gold winner from Hong Kong at the Guangdong-Hong Kong-Macao Greater Bay Area High-value Patent Portfolio Competition 2023, which was organized by Guangdong intellectual Property Administration, The People's Government of Guangzhou Municipality, Hong Kong Intellectual Property Department and Macao Economic and Technological Development Bureau. In 2022, it was the only winner in the life and health category of the inaugurating BOCHK Science and Technology Innovation Prize, which was established by the Hong Kong Alliance of Technology and Innovation (HKATI) and sponsored by the Bank of China (Hong Kong) Limited.

 

 

BACA JUGA:Teledyne FLIR IIS, Perluas Seri Kamera Forge, Peringkat IP67

Gobi Partners GBA (Gobi GBA) was established in 2016 as a part of the leading Pan-Asian venture capital platform Gobi Partners. Gobi GBA is the general partner of the Alibaba Hong Kong Entrepreneurs Fund（AEF）as well as the AEF Greater Bay Area Fund and has formed strategic partnerships with other renowned financial institutions such as HSBC and Hang Seng Bank. As of 2023, Gobi GBA has invested in over 80 startups across the Greater Bay Area and has fostered the growth of 8 unicorns including Airwallex, Amber, Animoca Brands, GoGoX, Prenetics, and more.

Sumber: media outreach newswire